Cell signaling discovery provides new hope for blood disorders
Walter and Eliza Hall Institute scientists have revealed new details about how cell signalling is controlled in the immune system, identifying in the process potential new therapeutic targets for treating severe blood disorders.
Medical research
Feb 16, 2012 |
5 / 5 (2) |
0
Stem cell treatments improve heart function after heart attack
Stem cell therapy moderately improves heart function after a heart attack, according to a systematic review published in The Cochrane Library. But the researchers behind the review say larger clinical trials are needed to ...
Medical research
Feb 14, 2012 |
5 / 5 (1) |
0
Researchers make breakthrough in stem cell research
(Medical Xpress) -- University of Queensland scientists have developed a world-first method for producing adult stem cells that will substantially impact patients who have a range of serious diseases.
Medical research
Feb 13, 2012 |
5 / 5 (5) |
0
|
New procedure bests standard of care for fixing damaged cartilage
A new study has demonstrated that a procedure wherein healthy cartilage is transplanted to fix an area of damaged cartilage (osteoarticular cartilage transplantation or OATS procedure) is superior to the standard of care ...
Arthritis & Rheumatism
Feb 08, 2012 |
not rated yet |
0
Identical twins reveal mechanisms behind aging
In a recent study led by Uppsala University, the researchers compared the DNA of identical (monozygotic) twins of different age. They could show that structural modifications of the DNA, where large or small DNA segments ...
Genetics
Feb 02, 2012 |
4.6 / 5 (15) |
0
|
Ontario's first cardiac stem cell transplant performed last week
Heart failure is a leading cause of death in Canada. As part of the ongoing IMPACT-CABG clinical trial to treat advanced heart failure, physicians at the Peter Munk Cardiac Centre performed the first cardiac stem cell transplant ...
Cardiology
Jan 26, 2012 |
5 / 5 (3) |
0
Natural enzyme provides potential new approach for treating graft-vs-host disease
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.
Medical research
Jan 17, 2012 |
not rated yet |
0
|
University of Kentucky offers stroke stem cell trial
The University of Kentucky will be the first site in the state and one of a select few in the entire country participating in the first stages of a groundbreaking study to investigate the effects of MultiStem, a human adult ...
Medical research
Jan 13, 2012 |
not rated yet |
0
New findings about the way cells work could lead to a test and therapy for kidney failure caused by E. coli
Ever since the water supply in Walkerton, Ont., was contaminated by E. coli in 2000, Dr. Philip Marsden has been trying to figure out just how a toxin released by that particular strain of the bacteria causes kidney damage ...
Diseases, Conditions, Syndromes
Jan 10, 2012 |
not rated yet |
0
|
Towards more effective treatment for multiple myeloma
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, ...
Cancer
Jan 09, 2012 |
5 / 5 (2) |
0
|
Bone marrow-derived cells differentiate in the brain through mechanisms of plasticity
Bone marrow-derived stem cells (BMDCs) have been recognized as a source for transplantation because they can contribute to different cell populations in a variety of organs under both normal and pathological conditions. Many ...
Medical research
Dec 19, 2011 |
not rated yet |
0
|
Bone marrow and blood stem cell transplant survival rates equal, when donor is unrelated to patient
Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft failure but less likely to experience graft-versus-host disease, ...
Medical research
Dec 12, 2011 |
not rated yet |
0
Researchers identify agent responsible for protection against early stages of atherosclerosis
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in ...
Cardiology
Dec 12, 2011 |
not rated yet |
0
|
Ruxolinitib better at reducing myelofibrosis symptoms, study shows
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills ...
Cancer
Dec 12, 2011 |
not rated yet |
0
Study points to novel way to improve outcomes from umbilical cord blood transplants
A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a ...
Cancer
Dec 12, 2011 |
not rated yet |
0
